NEOGEN CORP Quarterly Common Stock, Shares Authorized from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Neogen Corp quarterly Common Stock, Shares Authorized history and growth rate from Q2 2011 to Q2 2024.
  • Neogen Corp Common Stock, Shares Authorized for the quarter ending May 31, 2024 was 315M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 315M 0 0% May 31, 2024 10-K 2024-07-30
Q1 2024 315M 0 0% Feb 29, 2024 10-Q 2024-04-09
Q4 2023 315M 0 0% Nov 30, 2023 10-Q 2024-01-09
Q3 2023 315M +195M +163% Aug 31, 2023 10-Q 2023-10-10
Q2 2023 315M 0 0% May 31, 2023 10-K 2024-07-30
Q1 2023 315M +195M +163% Feb 28, 2023 10-Q 2023-04-04
Q4 2022 315M +195M +163% Nov 30, 2022 10-Q 2023-01-09
Q3 2022 120M 0 0% Aug 31, 2022 10-Q 2022-09-30
Q2 2022 315M +195M +163% May 31, 2022 10-K 2023-08-15
Q1 2022 120M 0 0% Feb 28, 2022 10-Q 2022-04-01
Q4 2021 120M 0 0% Nov 30, 2021 10-Q 2021-12-30
Q3 2021 120M 0 0% Aug 31, 2021 10-Q 2021-09-30
Q2 2021 120M 0 0% May 31, 2021 10-K 2022-07-27
Q1 2021 120M 0 0% Feb 28, 2021 10-Q 2021-03-31
Q4 2020 120M 0 0% Nov 30, 2020 10-Q 2020-12-29
Q3 2020 120M 0 0% Aug 31, 2020 10-Q 2020-09-30
Q2 2020 120M 0 0% May 31, 2020 10-K 2021-07-30
Q1 2020 120M 0 0% Feb 29, 2020 10-Q 2020-04-03
Q4 2019 120M +60M +100% Nov 30, 2019 10-Q 2019-12-27
Q3 2019 120M +60M +100% Aug 31, 2019 10-Q 2019-09-26
Q2 2019 120M 0 0% May 31, 2019 10-K 2020-07-30
Q1 2019 120M +60M +100% Feb 28, 2019 10-Q 2019-03-29
Q4 2018 60M 0 0% Nov 30, 2018 10-Q 2018-12-28
Q3 2018 60M 0 0% Aug 31, 2018 10-Q 2018-10-05
Q2 2018 120M +60M +100% May 31, 2018 10-K 2019-07-30
Q1 2018 60M 0 0% Feb 28, 2018 10-Q 2018-03-29
Q4 2017 60M 0 0% Nov 30, 2017 10-Q 2018-01-05
Q3 2017 60M 0 0% Aug 31, 2017 10-Q 2017-09-29
Q2 2017 60M 0 0% May 31, 2017 10-K 2018-07-27
Q1 2017 60M 0 0% Feb 28, 2017 10-Q 2017-03-31
Q4 2016 60M 0 0% Nov 30, 2016 10-Q 2016-12-29
Q3 2016 60M 0 0% Aug 31, 2016 10-Q 2016-09-30
Q2 2016 60M 0 0% May 31, 2016 10-K 2017-07-28
Q1 2016 60M 0 0% Feb 29, 2016 10-Q 2016-03-31
Q4 2015 60M 0 0% Nov 30, 2015 10-Q 2016-01-08
Q3 2015 60M 0 0% Aug 31, 2015 10-Q 2015-09-30
Q2 2015 60M 0 0% May 31, 2015 10-K 2016-07-29
Q1 2015 60M 0 0% Feb 28, 2015 10-Q 2015-04-01
Q4 2014 60M 0 0% Nov 30, 2014 10-Q 2014-12-30
Q3 2014 60M 0 0% Aug 31, 2014 10-Q 2014-09-30
Q2 2014 60M 0 0% May 31, 2014 10-K 2015-07-30
Q1 2014 60M 0 0% Feb 28, 2014 10-Q 2014-04-04
Q4 2013 60M 0 0% Nov 30, 2013 10-Q 2014-01-09
Q3 2013 60M 0 0% Aug 31, 2013 10-Q 2013-09-30
Q2 2013 60M 0 0% May 31, 2013 10-K 2014-07-30
Q1 2013 60M 0 0% Feb 28, 2013 10-Q 2013-03-28
Q4 2012 60M 0 0% Nov 30, 2012 10-Q 2012-12-28
Q3 2012 60M +30M +100% Aug 31, 2012 10-Q 2012-09-28
Q2 2012 60M 0 0% May 31, 2012 10-K 2013-07-30
Q1 2012 60M Feb 29, 2012 10-Q 2012-03-30
Q4 2011 60M Nov 30, 2011 10-Q 2011-12-30
Q3 2011 30M Aug 31, 2011 10-Q 2011-09-30
Q2 2011 60M May 31, 2011 10-K 2012-07-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.